Patient Enrollment and Data Analysis

患者登记和数据分析

• 批准号: 8464249
• 负责人: Andrew S Weyrich
• 金额: $ 31.89万
• 依托单位: UNIVERSITY OF UTAH
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-05-01 至 2017-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8464249
• 关键词: Age; Bioinformatics; Blood; Blood Clot; Blood Platelets; Blood coagulation; Blood specimen; Cells; Center for Translational Science Activities; Clinical; Clinical Sciences; Consent; Data; Data Analyses; Databases; Enrollment; Ensure; Gender; Glucose; Goals; Housing; Human; Instruction; Lead; Lipids; Metabolic; Metabolic syndrome; Methods; Molecular Medicine; Non-Insulin-Dependent Diabetes Mellitus; Obesity; Participant; Patient Education; Patients; Process; Prospective Studies; RNA Sequences; Recruitment Activity; Registries; Research; Research Design; Research Personnel; Research Project Grants; Risk; Sample Size; Services; Statistical Data Interpretation; Thrombosis; Tissues; Translational Research; Universities; Utah; Wing; Work; arm; data management; diabetes management; experience; inclusion criteria; insight; meetings; next generation; patient responsibilities; programs; software development; statistics

PROJECT SUMMARY (See instructions): The primary responsibility of the Patient Enrollment and Data Analysis Core (Core B) is to identify and recruit healthy lean control subjects as well as patients with type 2 diabetes and obesity for Projects 1-4 and provide specialized data analysis support for the University of Utah Molecular Medicine Translational Research Center in Thrombosis (U2M2-TRCT). A team of investigators with expertise in thrombosis and metabolic syndromes will lead Core B. This core also includes a clinical coordinator, database manager, and investigators with experience in statistics and bioinformatics. Core B will directly interact with Core C regarding isolation of human platelets from patients with metabolic syndromes and provide support for all four research projects. Patients enrolled through Project 3 will be identified and recruited by Core C using successful methods described in the Core description. The Core will utilize the University of Utah Clinical Center in Translational Science (CCTS) to enhance patient enrollment and study initiation. Core B will be responsible for entering patient data and management of the U-STAR (The Utah Study of Translational Science And Research Registry) database. In addition to recruiting, enrolling, and managing data, Core B will provide statistical and bioinformatics support for all of the projects. The statistics wing will provide sample size and power calculations, assist with study design, and analyze experimental data. The bioinformatics arm will provide support for the next-generation RNA-sequencing studies proposed by U2M2-TRCT investigators. This includes data interpretation, statistical support, and software development. The services provided by Core B, which is centrally located and readily available to all U2M2-TRCT participants, will ensure that enrollment goals are met and exceeded and that data analysis occurs seamlessly within the program.

项目总结(见说明)： 患者登记和数据分析核心(核心B)的主要责任是为项目1-4识别和招募健康的瘦控制受试者以及2型糖尿病和肥胖症患者，并为犹他大学分子医学血栓转化研究中心(U2M2-TRCT)提供专门的数据分析支持。一支在血栓形成和代谢方面具有专业知识的研究团队 综合症将领导核心B。核心B还包括一名临床协调员、数据库经理和具有统计和生物信息学经验的调查人员。核心B将直接与核心C就从代谢综合征患者中分离人类血小板进行互动，并为所有四个研究项目提供支持。通过项目3登记的患者将由Core C使用以下方式识别和招募 核心描述中描述的成功方法。CORE将利用犹他大学临床转化科学中心(CCTS)来加强患者登记和研究启动。核心B将负责输入患者数据和管理U-STAR(犹他州翻译科学和研究注册局研究)数据库。除了招聘、登记和管理数据外，Core B 将为所有项目提供统计和生物信息学支持。统计部门将提供样本大小和功率计算，协助研究设计，并分析实验数据。生物信息学部门将为U2M2-TRCT研究人员提出的下一代RNA测序研究提供支持。这包括数据解释、统计支持和软件开发。这个 核心B位于中心位置，所有U2M2-TRCT参与者都可以随时获得该中心提供的服务，它将确保达到并超过注册目标，并确保在该计划内无缝地进行数据分析。